AGITG Trial news: The AGITG currently has fourteen studies open to recruitment and three studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Recruitment Period (months) | Date of First Site Open (ANZ) | Number of Sites Open (ANZ) | |
| ACTICCA-1 | 22 | 40 | 36 | 25 July 2016 | 13 |
| ASCOLT | 409 | 400 | 48 | 18 June 2014 | 32 |
| ASCOLT – Global | 1486 | 1587 | |||
| DYNAMIC-III | 335 | 1000 | 54 | 09 October 2017 | 36 |
| DYNAMIC-Pancreas | 17 | 438 | 54 | 01 March 2019 | 19 |
| DYNAMIC-Rectal | 113 | 408 | 36 | 18 June 2018 | 27 |
| INTEGRATE II | 68 | 90 | 48 | 19 October 2016 | 27 |
| INTEGRATE II – Global | 184 | 350 | |||
| MASTERPLAN | 1 | 120 | 48 | 01 October 2019 | 4 |
| MONARCC | 14 | 80 | 24 | 20 June 2018 | 17 |
| NABNEC | 37 | 58 | 54 | 15 September 2016 | 16 |
| Neo-CREATE | 3 | 20 | 36 | 17 June 2019 | 1 |
| PALEO | 1 | 54 | 36 | 16 September 2019 | 1 |
| RENO | 14 | 250 | 36 | 21 January 2019 | 2 |
| SPAR | 39 | 222 | 48 | 13 April 2018 | 15 |
| TOP GEAR | 235 | 280 | 118 | 29 September 2009 | 20 |
| TOP GEAR – Global | 533 | 570 |
Recruitment figures are for Australian and New Zealand sites as at end February 2020.
Trial Results Lay Summaries (click on the links below):
ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST